论文部分内容阅读
目的：回顾１００ 例眼球摘除术后羟基磷灰石义眼座眼窝成形术的体会，旨在探讨该手术出现的问题及处理。方法：采用巩膜包裹羟基磷灰石球作为眼球摘除术后眼窝成形的充填物，其中自体巩膜包裹羟基磷灰石球一期植入者６１ 例，异体巩膜包裹羟基磷灰石球二期植入者３９ 例。结果：随访６ ～２４个月，除２ 例因故取出（ 其中１ 例因眶内感染） ，余均获满意的外观且义眼运动良好。其它问题还有结膜变薄３ 例；结膜延迟愈合７ 例；植入物略下移１ 例（ 因二期植入时，下直肌未找到） 。无植入物排除现象。结论：用羟基磷灰石义眼座充填适合于任何眼球摘除术后需要进行眶内植入的患者，无其它义眼座所常见的高排斥率及感染率。为进一步降低手术并发症，应注意选择手术适应证及避免手术操作疏忽。
OBJECTIVE: To review the experience of 100 cases of hydroxyapatite orbital ophthalteroplasty after enucleation, in order to explore the problems and the treatment of this operation. Methods: Sclera was used to enclose hydroxyapatite ball as a filling for orbital foramen after enucleation. Among them, 61 cases were implanted with hydroxyapatite ball in the sclera, 39 cases. Results: All the patients were followed up for 6-24 months. Except for 2 cases (one of them was infected by orbit), the satisfactory appearance and good eye movements were obtained. Other problems were 3 cases of conjunctival thinning, 7 cases of conjunctival delayed healing, and 1 case of implants slightly downward (not found in lower rectus muscle due to second-stage implantation). No implant exclusion. CONCLUSIONS: Hydroxyapatite orbital prosthesis is suitable for patients who require intraorbital implantation after any enucleation, and does not have the high rejection and infection rates commonly seen in other eyelids. In order to further reduce the surgical complications, we should pay attention to choose the surgical indications and to avoid surgical negligence.